Contact
Please use this form to send email to PR contact of this press release:
Safirstein Metcalf LLP and HGT Law Update on Valeant Pharmaceuticals International Inc. Investor Class Action - VRX
TO:
Sheila Feerick
Safirstein Metcalf LLP
2122012856